HPV Vaccine Integrated Service Implementation Research in Ethiopia
Launched by POPULATION SERVICES INTERNATIONAL · Oct 30, 2024
Trial Information
Current as of August 23, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial, called the HPV Vaccine Integrated Service Implementation Research in Ethiopia, aims to find out how to improve access to the HPV vaccine for young girls aged 9 to 14 in rural areas of Ethiopia. Researchers want to see if a special program that addresses gender norms and barriers can help more girls get vaccinated compared to a program that does not focus on these issues. They will compare vaccination rates in areas that use this new approach with those that don't over about two years.
To participate in the study, girls who are 9 to 14 years old and their parents or guardians must provide consent. Participants will be asked to answer simple questions after receiving the vaccine and share their thoughts about the service. The study will also include interviews and group discussions to gather more insights. This trial is important because it aims to improve health services for adolescents and ensure that more young girls can receive the HPV vaccine, which can help protect them from certain cancers in the future.
Gender
ALL
Eligibility criteria
- • Exclusion Criteria for key informant interviews
- • - Does not provide informed consent
- Inclusion Criteria for focus group discussions and in-depth interviews:
- • Girl: aged 9-14 years, female
- • Caregiver: Parent/legal guardian of eligible 9-14-year-old girl (above); 18 years of age or older
- Exclusion Criteria:
- • Girl: Does not provide informed assent, including to audio-recording, Parent/legal guardian does not provide consent
- • Caregiver: Does not provide informed consent, including to audio-recording
- Inclusion Criteria for exit interviews:
- • Girl accompanied by adult (18+) parent/legal guardian: Aged 9-14 years old; Female; Received a VYA health services supported by the program\*, including HPV vaccination, on the date of recruitment
- • Girl accompanied by an/other adult(s) (18+): Aged 9-14 years old; Female; Received a VYA health services supported by the program\*, including HPV vaccination, on the date of recruitment
- • Girl accompanied by an/other minor(s) only: Aged 9-14 years old; Female; Received a VYA health services supported by the program\*, including HPV vaccination, on the date of recruitment
- • Girl completely unaccompanied: Aged 9-14 years old; Female; Received a VYA health services supported by the program\*, including HPV vaccination, on the date of recruitment
- • Caregiver: Parent/legal guardian or caregiver of eligible 9-14-year-old girl (above); Accompanying eligible 9-14-year-old girl (above) during care/service visit; 18 years of age or older
- Exclusion Criteria:
- • Girl accompanied by adult (18+) parent/legal guardian: Does not provide informed assent; Parent/legal guardian does not provide consent; Requires urgent medical treatment or referral
- • Girl accompanied by an/other adult(s) (18+): • Does not provide informed assent; Caregiver does not provide permission; Requires urgent medical treatment or referral
- • Girl accompanied by an/other minor(s) only or completely unaccompanied: Does not provide informed assent; Requires urgent medical treatment or referral
- • Caregiver: Does not provide informed consent
About Population Services International
Population Services International (PSI) is a global non-profit organization dedicated to enhancing the health and wellbeing of individuals in low- and middle-income countries through innovative and evidence-based interventions. With a strong focus on sexual and reproductive health, PSI employs strategic partnerships and community engagement to deliver essential health services and products, driving sustainable behavioral change. By leveraging data-driven approaches and conducting rigorous clinical trials, PSI aims to inform public health policies and improve health outcomes, ultimately contributing to healthier populations and stronger communities worldwide.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Wakgari Deressa, PhD MPH
Principal Investigator
College of Health Sciences, Addis Ababa University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported